Insights into gemcitabine resistance and the potential for therapeutic monitoring

[1]  R. Powers,et al.  Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility , 2017, Antimicrobial Agents and Chemotherapy.

[2]  R. Powers,et al.  Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells , 2017, Journal of proteome research.

[3]  Quan P. Ly,et al.  MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. , 2017, Cancer cell.

[4]  Quan P. Ly,et al.  MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. , 2017, Cancer cell.

[5]  Karen H. Vousden,et al.  Serine and one-carbon metabolism in cancer , 2016, Nature Reviews Cancer.

[6]  L. Cantley,et al.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion , 2016, Nature.

[7]  Hinrich W. H. Göhlmann,et al.  Understanding drugs in breast cancer through drug sensitivity screening , 2015, SpringerPlus.

[8]  M. Hasan,et al.  Cancer Metabolism and Drug Resistance , 2015, Metabolites.

[9]  Daya Luo,et al.  Effect of taurine on the proliferation and apoptosis of human hepatocellular carcinoma HepG2 cells. , 2015, Experimental and therapeutic medicine.

[10]  Kristine Glunde,et al.  Choline metabolism-based molecular diagnosis of cancer: an update , 2015, Expert review of molecular diagnostics.

[11]  Robert Powers,et al.  Staphylococcus aureus Metabolic Adaptations during the Transition from a Daptomycin Susceptibility Phenotype to a Daptomycin Nonsusceptibility Phenotype , 2015, Antimicrobial Agents and Chemotherapy.

[12]  R. Pirola,et al.  Pancreatic Stellate Cells , 2015 .

[13]  T. Gocho,et al.  Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation , 2014, Molecular Cancer Therapeutics.

[14]  R. Hammer,et al.  Acetate Dependence of Tumors , 2014, Cell.

[15]  Gisele Monteiro,et al.  Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. , 2014, European journal of pharmacology.

[16]  Sarah A Heerboth,et al.  Drug Resistance in Cancer: An Overview , 2014, Cancers.

[17]  Nicolas Widmer,et al.  Therapeutic drug monitoring in cancer--are we missing a trick? , 2014, European journal of cancer.

[18]  J. Lehn,et al.  Myo‐inositol trispyrophosphate‐mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy , 2014, International journal of cancer.

[19]  I. Amelio,et al.  Serine and glycine metabolism in cancer☆ , 2014, Trends in biochemical sciences.

[20]  Robert Powers,et al.  MVAPACK: A Complete Data Handling Package for NMR Metabolomics , 2014, ACS chemical biology.

[21]  R. Powers,et al.  Application of NMR metabolomics to search for human disease biomarkers. , 2012, Combinatorial chemistry & high throughput screening.

[22]  R. Powers,et al.  MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer , 2012, Proceedings of the National Academy of Sciences.

[23]  A. Dalgleish,et al.  Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide. , 2011, Anticancer research.

[24]  Yoshiro Saito,et al.  Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment* , 2010, Molecular & Cellular Proteomics.

[25]  J. Davies,et al.  Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.

[26]  Shelly C. Lu.  Regulation of glutathione synthesis. , 2009, Molecular aspects of medicine.

[27]  Ivana Vucenik,et al.  Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. , 2003, The Journal of nutrition.

[28]  T. Hara,et al.  PET imaging of prostate cancer using carbon-11-choline. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Stephen,et al.  Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. , 1981, Cancer research.